Assuntos
Humanos , Idoso , Analgésicos , Anti-Inflamatórios , Exercício Físico , Terapia por Exercício , Osteoartrite , Doenças ReumáticasRESUMO
This study is a cross-sectional analysis of the differences between SLE outpatients seen in Rheumatology departments at University centres in England, Brazil and Sweden, using a standard protocol. The demographic characteristics, extent and activity of disease of 209 patients with SLE were studied; 112 patients were seen in England, 33 in Brazil and 64 in Sweden. The median age of disease onset of Brazilian and English patients was 25 years and of Swedish patients 31.5 years. Disease activity was measured by the BILAG index. In most systems Brazilian patients experienced more activity than English patients and English patients more activity than Swedish patients. Non-Caucasians experienced more active disease than Caucasians. No sex or occupational differences were observed in disease activity. English patients were the most likely to have experienced photosensitivity, oral ulcers and haematological disorders, Brazilian patients renal disorders and Swedish patients discoid rashes. Brazilian patients were the most likely to be prescribed only one drug for treatment of SLE and to be taking steroids and the highest dose of steroids, in contrast to the European patients who were often prescribed steroids and an antimalarial agent or azathioprine. The results of this cross-sectional assessment of disease activity using a standardized instrument indicate that there are real differences in the extent and degree of activity of SLE in different national groups. This reflects a combination of genetic, environmental and social influences on disease expression and has implications for treatment and monitoring of SLE patients.
Assuntos
Lúpus Eritematoso Sistêmico/etnologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Brasil , Estudos Transversais , Inglaterra , Feminino , Humanos , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Fatores Sexuais , Fatores Socioeconômicos , SuéciaRESUMO
A esclerose sistemica progressiva (ESP) caracteriza-se por um excesso de deposito de colageno na pele e nos orgaos internos.Nos ultimos anos, com um melhor conhecimento da sintese e catabolismo das fibras do colageno,tornou-se possivel desfrutarmos melhores condutas terapeuticas para ESP. Os autores estudaram o efeito da colchicina oral sobre a sintese do colageno em 5 pacientes portadores de ESP pelo criterio da American Rheumatism Association, no periodo de 1 ano. Tres pacientes mostraram boa resposta, avaliados pelos indices de abertura da boca e pelas provas de funcoes pulmonares
